Inventor · disambiguated record
Robert John Konrad
Also filed as: KONRAD ROBERT · KONRAD ROBERT JOHN
8 granted patents·2 pending applications·11 citations·filing 2000–2023
79Inventor score
Top patents by PatentIndex Score
10 records- 0173US12180270B2Anti-ANGPTL 3/8 complex antibodies and methods of using the sameLILLY CO ELI·Filed 2021·Granted Dec 31, 2024·0 cites·16 claims
- 0271US12459997B2Compounds and methods targeting interleukin-19LILLY CO ELI·Filed 2023·Granted Nov 4, 2025·0 cites·2 claims
- 0370US11492395B2Polynucleotides for preparing ANGPTL 3/8 complexesLILLY CO ELI·Filed 2021·Granted Nov 8, 2022·0 cites·8 claims
- 0470US6589995B2Method of inhibiting pancreatic β-cell p135 O-glycosylationUAB RESEARCH FOUNDATION·Filed 2001·Granted Jul 8, 2003·4 cites·1 claims
- 0567US11591387B2Compounds and methods targeting interleukin-19LILLY CO ELI·Filed 2020·Granted Feb 28, 2023·0 cites·10 claims
- 0664US11242383B2Anti-ANGPTL ⅜ complex antibodies and methods of using the sameLILLY CO ELI·Filed 2019·Granted Feb 8, 2022·0 cites·33 claims
- 0764US10919959B2ANGPTL3/8 complexes and methods of using the sameLILLY CO ELI·Filed 2019·Granted Feb 16, 2021·0 cites·2 claims
- 0863US6361995B1Protection of pancreatic β-cells during islet isolation and assessment of islet viability and candidate diabetes drugs after islet isolationUAB RESEARCH FOUNDATION·Filed 2000·Granted Mar 26, 2002·7 cites·4 claims
- 0957US2024059770A1Oxyntomodulin binding molecules, and uses thereofLILLY CO ELI·Filed 2022·Application pending·0 cites
- 1045US2003186948A1O-linked N-acetylglucosamine pathway in the pathogenesis of neurodegeneration and diabetesFiled 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Robert John Konrad files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →